Inno Laser Technology Co., Ltd.

SZSE:301021 Stok Raporu

Piyasa değeri: CN¥3.5b

Inno Laser Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Inno Laser Technology has a total shareholder equity of CN¥976.7M and total debt of CN¥13.0M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥1.2B and CN¥224.2M respectively.

Anahtar bilgiler

1.3%

Borç/özkaynak oranı

CN¥13.00m

Borç

Faiz karşılama oranın/a
NakitCN¥321.76m
EşitlikCN¥976.69m
Toplam yükümlülüklerCN¥224.24m
Toplam varlıklarCN¥1.20b

Son finansal sağlık güncellemeleri

Recent updates

Inno Laser Technology Co., Ltd.'s (SZSE:301021) 39% Share Price Surge Not Quite Adding Up

Oct 14
Inno Laser Technology Co., Ltd.'s (SZSE:301021) 39% Share Price Surge Not Quite Adding Up

Inno Laser Technology (SZSE:301021) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Oct 08
Inno Laser Technology (SZSE:301021) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Inno Laser Technology Co., Ltd.'s (SZSE:301021) 34% Price Boost Is Out Of Tune With Revenues

Jul 23
Inno Laser Technology Co., Ltd.'s (SZSE:301021) 34% Price Boost Is Out Of Tune With Revenues

Optimistic Investors Push Inno Laser Technology Co., Ltd. (SZSE:301021) Shares Up 31% But Growth Is Lacking

Mar 06
Optimistic Investors Push Inno Laser Technology Co., Ltd. (SZSE:301021) Shares Up 31% But Growth Is Lacking

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 301021's short term assets (CN¥833.7M) exceed its short term liabilities (CN¥200.3M).

Uzun Vadeli Yükümlülükler: 301021's short term assets (CN¥833.7M) exceed its long term liabilities (CN¥23.9M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 301021 has more cash than its total debt.

Borcun Azaltılması: 301021's debt to equity ratio has reduced from 18.3% to 1.3% over the past 5 years.

Borç Kapsamı: 301021's operating cash flow is negative, therefore debt is not well covered.

Faiz Kapsamı: Insufficient data to determine if 301021's interest payments on its debt are well covered by EBIT.


Bilanço


Sağlıklı şirketleri keşfedin